Gyre Therapeutics, Inc. (GYRE)

CIK 1124105 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Gyre Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Sep 1, 20268-K0001140361-26-035189
Aug 31, 2026S-80001140361-26-034882
Aug 26, 20268-K0001140361-26-034401
Aug 7, 20268-K0001193125-26-339223
Aug 7, 202610-Q0001193125-26-340448
Aug 4, 202640001140361-26-031326
Aug 4, 202630001140361-26-031322
Aug 4, 202630001140361-26-031320
Aug 4, 202640001140361-26-031324
Aug 3, 2026EFFECT9999999995-26-002523
Jul 16, 20268-K0001140361-26-028716
Jul 15, 20268-K/A0001140361-26-028564
Jul 13, 2026S-3/A0001140361-26-028333
Jun 30, 202640001140361-26-027005
Jun 30, 202640001140361-26-027008
Jun 30, 202640001140361-26-027006
Jun 30, 202640001140361-26-027007
Jun 30, 202640001140361-26-027003
Jun 30, 202640001140361-26-027004
Jun 23, 2026S-30001140361-26-025999
Jun 22, 202640001140361-26-025950
Jun 16, 20268-K0001140361-26-025324
Jun 15, 202640001140361-26-025208
Jun 11, 202640001140361-26-024929
Jun 10, 2026S-80001140361-26-024702